India to Lithuania: Tamoxifen Export Trade Route

The India to Lithuania Tamoxifen corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $71.9K USD. The route is dominated by PRAVA PHARMACEUTICALS PRIVATE LIMITED , which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's tamoxifen manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $9.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with tamoxifen's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 32.7%, placing it at rank #12 among India's top tamoxifen export destinations globally.

On the import side, key buyers of Indian tamoxifen in Lithuania include INTEREST MEDICAL , TO THE ORDER , TO THE ORDER FOR COUNTRY LT. INTEREST MEDICAL is the single largest importer with 2 shipments valued at $37.8K USD.

India's tamoxifen exports to Lithuania are driven primarily by a handful of large-scale manufacturers. PRAVA PHARMACEUTICALS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Lithuania benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — PRAVA PHARMACEUTICALS PRIVATE LIMITED , CHANDRA BHAGAT PHARMA LIMITED , BIOZENTA LIFESCIENCE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $9.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as tamoxifen tablets bp 10mg brand:blasto- and pharmaceutical product b no ot25014 m 3 25 e 2 27 ot25016 m 4 25 e 3 27 tamoxifen tablets bp 10mg, suggesting that buyers in Lithuania tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, INTEREST MEDICAL is the largest importer with 2 shipments worth $37.8K USD — representing 53% of all tamoxifen imports from India on this route.